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INTRODUCTION 
Thalassemia as the most common genetic disorder 
worldwide is regarded as a serious problem in public 
health issues in the Mediterranean region, Southeast Asia, 
the Indian subcontinent and the Middle East, including 
Iran.
1,2
 Iran is located on the thalassemia belt in the world 
and thalassemia carriers are evaluated from 1 to 10 
percent [average % 4.5] transitively.
3
 According to the 
statistics, the number of patients with thalassemia major 
(the most severe form of thalassemia) in Iran is more than 
20,000 individuals.
4
 Thalassemia affects the synthesis of 
globin chain and according to the number and type of the 
involved chains, clinical symptoms vary. Beta-
thalassemia is the most common frequent type of 
thalassemia which presents in three forms: thalassemia 
minor which leads to a mild asymptomatic haemolytic 
anaemia, thalassemia intermediate and major. 
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Background: Thalassemia as the most common genetic disorder worldwide is regarded as a serious problem in 
public health issues in the Mediterranean region. Patients with beta-thalassemia major experience physical, 
psychological and social problems that lead to decreased quality of life. The aim of this study was to assess health-
related quality of life and its determinants among patients with major beta-thalassemia. 
Methods: This was a population-based cross-sectional survey of quality of life. Population with thalassemia major 
(aged ≥ 2 years) of both genders who had records in Thalassemia Clinic of Bu-Ali Hospital, and those who regularly 
refer for blood transfusion or follow-up visits. Data were collected from December 2013 to May 2014.The self-
administered short form-36 (SF-36) questionnaire was used to measure quality of life in patients with thalassemia. 
Data were analysed using descriptive statistical tests (mean, SD, and frequency), and inferential statistical test (t-test) 
in SPSS.17 software. 
Results: Our samples were 20 men and 23 women. The median age was 20 years (2-42). After reviewing the patients' 
quality of life, it was observed that the mean score for physical function was 79.8, role limitations due to physical 
reasons 78.8, bodily pain 74.4, general health 59.1, fatigue or vitality 63.3, social function 70.21, role limitations due 
to psychological reasons (emotional) 77.3 and mental health 65.4. On two scales, role physical (P = 0.33) and role 
emotional (P = 0.13), the men showed significantly lower scores than the women. 
Conclusions: After reviewing the patients' quality of life, the highest quality in physical function and lowest quality 
in general health of patients were observed. In the quality of care data all scales were in very good level except 
general health. 
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Interestingly, thalassemia major is the most severe form 
of beta-thalassemia leading to severe anaemia and 
patients are in need of blood transfusion since the young 
age; this type may end in heart failure , due to iron 
overload, or early death in childhood in case of no 
transfusion.
5
 Nowadays, with improvements in the 
treatment of patients with thalassemia, these patients have 
a longer life expectancies and a larger number of them 
reach older ages.
6
 As a result of this increase in life 
expectancy, their needs also change and entities such as 
continuing education, career and family making become 
more prominent amongst them.
7
 It is then anticipated that 
effective and suitable life background would be prepared 
for them in the society and they become as active as other 
members of the society.
8
 An increase in the life 
expectancy is accompanied by certain challenges such as 
bone diseases, infertility, consecutive referrals for blood 
transfusion, subcutaneous infusion of chelators, and 
moral stresses, which these aforementioned problems 
would affect mental, physical, social and educational 
functions of these patients.
1,7
 Hence, authorities who 
provide services to patients should be aware of the related 
mental and social consequences in addition to the burden 
of this disease, just like any other chronic disease, to 
prepare better living environment for these patients.
8
 
Therefore, in this study, we aimed to measure the Quality 
of life in patients with beta-thalassemia major using SF-
36 for the first time in who referred to Thalassemia Clinic 
of BU-Ali Hospital in Ardabil, Iran.  
METHODS 
This is a cross-sectional study that has been done on 
patients (aged ≥ 2 years) with major beta-thalassemia of 
both genders attending the Haematology & Oncology 
Center of Bu-Ali Hospital in Ardabil province, located on 
the North West of Iran. Data were collected between 
December 2013 and May 2014. The total sample was 43. 
No sample size calculations were carried out prior to the 
study. We assessed Thalassemia Major Patients who were 
dependent on blood transfusions, and who visited for 
monthly blood transfusions and clinical examinations. 
Thalassemia major diagnosis was based on the results of 
electrophoresis of blood haemoglobin. The study protocol 
was approved by both the Institutional Review Board and 
the Ethics Committee of Ardabil University of Medical 
Science. Informed written consent was obtained from all 
patients. For data collection, questionnaires were used. 
The researcher-made demographic questionnaire included 
age, gender, educational level employment status, marital 
status. The Persian version of the SF-36 questionnaire 
was used in this study, and this had previously been 
translated from English and validated (9).This 
questionnaire evaluated the general health of thalassemia 
major patients according to 8 categories: physical 
functioning (PF), role-physical (RP), bodily pain (BP), 
general health (GH), vitality (VT), social functioning 
(SF), role-emotional (RE) and mental health (MH). The 
Cronbach alpha for the reliability of this questionnaire 
has been found to range from 0.77 to 0.90 in Iran and 
from 0.65 to 0.96 in other countries.
10
 The total score of 
these 8 indices ranged between 0 and 100, with 
designations of weak (≤20), bad (21-40), good (41-60), 
very good (61-80), and excellent (>81).
10
 Questionnaires 
were written through interviews and completed by trained 
students. Explanations about the disease and reasons for 
conducting this study were given to the patients, and 
permission to complete the questionnaire was obtained 
from the patient and parents. Literate patients were asked 
to complete the questionnaire themselves if they wished. 
Those who were illiterate were assisted by a trained 
researcher. Considering the young age of the patients, 
questions were asked, and interviews were conducted in 
such a way so as not to undermine integrity and 
independence of questions. Data was analysed using 
descriptive statistics (frequency, mean, and standard 
deviation) and inferential statistics (t-test) in SPSS-16 
software. P-value of less than 0.05 was considered 
statistically significant. 
RESULTS 
Table 1: Socio-demographic data of samples. 
Age (years) n % 
2-12 5 11.6 
12-2 19 44.1 
22-32 16 37.2 
≥ 32                            3 6.9 
Gender 
Male 20 46.5 
Female 23 53.4 
Marital status 
Single  25 58.1 
Married 18 41.9 
Level of education 
Illiterate 3 7 
Primary 26 60.5 
Intermediate 10 23.2 
Secondary 4 9.3 
Employment status 
Student 8 18.7 
Retired 0 0 
Employed 4 9.3 
Jobless 31 72 
Economic class 
Low Income 12 27.9 
Moderate 
Income 
9 20.9 
High Income 22 51.2 
In our study, we included 43 patients with beta-
thalassemia major aged between 2 and 42 years of age 
(mean =20.32 and SD =8.47) (range, 2– 42 years). Males 
made up 46.5% of our sample. 25 subjects (58.1%) were 
single and 18 (41.9%) was married. Table1 showed 
demographic characteristics of participants. The mean 
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scores on the 8 indexes of the SF-36 Test are shown in 
Table 2. Physical functioning index had the highest mean 
score [79.8 (SD 31)], while General Health had the 
lowest mean score [59.1 (SD 20.7)]. Scores between 80 
and 100 for each of the 8 indexes were achieved by 27 
patients (62.7.9%) for physical functioning, 28 (65.1%) 
for Role-physical, 19 (44.1%) for bodily pains, 9 (21%) 
for general health, 10 (23.2%) for vitality, 15 (34.8%) for 
social functioning, 27 (62.7%) for role-emotional, and 14 
(32.5%) for mental health. According to the analysis, 
although the female participants had a higher score in all 
domains except for RE & RP, when compared to the 
male participants, such a difference was only significant 
in SF and GH domains (p<0.05)(Figure 1). Unlike 
income, there wasn't any significant relationship between 
age and the quality of life scores (p>0.005). 
 
Figure 1: SF-36 domain scores in male and female 
patients. 
DISCUSSION 
Thalassemia Major has become a major general health 
problem throughout the world, especially in developing 
and poor countries.
9
 Thalassemia major is usually 
recognized in childhood, at which time patients begin 
treatment. Over their lives, however, patients and their 
families are at risk for social and behavioural disorders. 
Due to distress from both the illness itself and the need 
for iron chelation, thalassemia subjects frequently display 
maladaptive coping strategies and high levels of anxiety 
with psychosocial dysfunction.
10 
The quality of life 
amongst the patients with thalassemia in Ardabil is very 
good in eight domains under study except general health 
compared to the rest of Iranian healthy members (Table 
2). Such a difference is not surprising since due to special 
physical conditions and problems related to their disease, 
patients are not anticipated to have a very good quality of 
life.
8
 The results of a study conducted by Safizadeh et al, 
on the quality of life among patients affected with 
thalassemia major aged sixteen years and older, in 
Kerman city revealed that they had a good quality of life 
in all domains, as in his study the highest score was seen 
in PF and SF, and the lowest score in BP and MH.
11
 
Another study conducted by AzarKeivan on the quality of 
life among patients affected with thalassemia (major and 
intermediate) aged eighteen years and older, in Tehran 
city revealed that they had a very good quality of life in 
all domains except for MH and BP compared to this 
present study, in her study the highest score was seen in 
PF and SF, and the lowest score in BP and MH.
12
 In a 
recent report by Hadi et al, it was reported that in Shiraz 
has demonstrated a better quality of life in all domains 
compared to this study, the highest score was seen in RP 
and Pf and the lowest score in GH and V.
13
 The only 
common point between these three studies and the 
present study was in PF domain which was better than the 
other domains; hence it seems that receiving suitable 
treatments would decrease the patients' physical 
problems. 
Table 2: Health-related quality of life of the patients 
with beta-thalassemia major, according to the Short 
Form-36 (SF-36) score. 
Score 
 
Total 
(n = 
43) 
Men 
(n = 
20) 
Women 
(n = 23) 
P-
value 
Physical 
Functioning 
(PF) 
79.8 
±  
31   
80.1 
± 
33.1 
81.1 
 ± 
28.1 
           
0.25 
Role-Physical 
(RP) 
78.8  
± 
18.5 
79.7 
± 
14.7 
78.1  
± 
21.6 
           
0.33 
Bodily Pain 
(BP) 
74 .4 
±  
22 
72.1  
± 
21.9 
76.4  
±  
22.4 
           
0.49 
General 
Health (GH) 
59.1 
 ±  
20.7 
55.7 
± 
22.1 
62.1  
±  
19.4 
           
0.03 
Vitality (VT) 
63.3  
±  
20.1 
61.2 
± 
20.2 
65.2  
±  
20.3 
           
0.17 
Social 
Functioning 
(SF) 
70.21  
±  
25.9 
67.7 
± 
27.5 
72.3  
±  
24.9 
           
0.01 
Role-
Emotional 
(RE) 
77.3  
± 
27.7 
78.7 
± 
26 
76.1  
±  
29.6 
           
0.13 
Mental Health 
(MH) 
 
65.4  
±  
19.1 
61.6 
± 
23.3 
68.8  
±  
14.2 
           
0.37 
In the present study, mean physical function (PF) score 
was 79.8, which is higher than the 69.1 reported by 
Ismail et al, who assessed the health-related quality of life 
in Malaysian children with thalassemia.
14
 Similarly, 
Caocci et al, reported a PF of 68.4 in a cohort of 
thalassemia patients from Syria, Palestine, and Iraq.
15
 In 
another study by Gharaibeh et al, a PF score of 54.2 in a 
cohort of Jordanian children was observed.
18
 Also in a 
study conducted by Amoudi et al, in Western Saudi 
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Arabia PF score was 61.4.
16
 However, all of the above 
findings disagrees with the results obtained in this 
study.PF score in Studies conducted in Iran by Khani et 
al, in southern coast of the Caspian sea was 73.58. 
Another study by Safizadeh in Kerman on the 209 
patients with thalassemia major, was 72.11 and in 
southern Iran on the One hundred and one patients with 
beta-thalassemia major was 86.9.
11,17,18 
The pattern in the 
RP score comes in tandem with PF score in our sample 
and in study conducted by Hadi et al, our sample 
concluded an RP score of 78.8, compared to 54.31 in the 
Southeast Iran study (n=13), 65.4 in Southern Iran(n=21), 
59.06 in Northern (n=20) & 74.2 in the Italian study 
(n=24).
13
 According to our findings of general health 
scale compared with other scale the lowest score to 
Assigned to the same view of the findings of Gollo in 
Italy in 2001 and 2009.
19
 In our study, higher income was 
a significant determinant of higher quality of life scores 
for the physical and mental health dimensions, as well as 
higher total scores. This was concordant with the results 
from Tajvar et al.
20
 In a study on an elderly Iranian 
population. Obviously, with better economic status, 
different populations and especially thalassemia patients 
would be able to confront their disease-related problems 
more easily. Among the population studied, 55.8% were 
not more than 22 years old. We did not find any 
significant correlation between age and the quality of life 
scores. Sobotaet al Investigated quality of life in a 
longitudinal thalassemia cohort aged over 14 years, 
compared with the norms in the United States, along with 
the influence of clinical factors.
21
 Differing from our 
results, they showed worse quality of life among older 
patients. The results have also demonstrated that sex is 
influential in GH domain and the girls' status seemed to 
be better. Although it sounds that problems resulting 
from thalassemia and its treatment are not any different 
between girls and boys, the expectations from the males 
in the society (such as managing a family, income, etc.) 
in Iran can justify these differences. In a study by Hadi, 
women had a better quality of life in SF domain whereas 
studies conducted in Thailand and Malaysia has shown 
that sex is not effective on the quality of life 
domains.
1,13,14
 
CONCLUSION 
All patients with thalassemia should undergo assessment 
of quality of life amongst so that interventions focusing 
on the affected domains can be implemented. In addition, 
patients with thalassemia and their families often require 
support in many aspects, especially psychological support 
to prevent mental disorders. 
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